SCHEMBL6441084

SCHEMBL6441084

CS(=O)(=O)c1ccc(-c2ccccc2-c2cc(C(=O)OCCCOCc3ccccc3)n[nH]2)cc1

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 8/20 0.39
PTGDR2 Q9Y5Y4 2/20 0.38
POLB P06746 1/20 0.35
GHSR Q92847 2/20 0.35
KMT2A Q03164 2/20 0.35
TP53 P04637 1/20 0.35
THRB P10828 1/20 0.35
MEN1 O00255 1/20 0.35
NPC1 O15118 1/20 0.35
MITF O75030 1/20 0.35
ALDH1A1 P00352 1/20 0.35
LMNA P02545 1/20 0.35
MAPT P10636 1/20 0.35
MAPK1 P28482 1/20 0.35
HTT P42858 1/20 0.35
RAB9A P51151 1/20 0.35
CCR6 P51684 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6441087 0.76 GHSR (0.40) PTGS2PTGDR2GHSRALDH1A1LMNA
SCHEMBL3867622 0.75 CA9 (0.54) PTGS2
SCHEMBL3864776 0.67 MDM2 (0.48) PTGS2
SCHEMBL69431 0.67 KMT2A (0.52) POLBKMT2ATP53THRBMEN1
SCHEMBL27309993 0.66 HCAR2 (0.49) PTGS2POLBKMT2AMEN1LMNA
SCHEMBL31335067 0.65 HCAR2 (0.51) POLBKMT2ATP53THRBNPC1
SCHEMBL27999806 0.64 ESR1 (0.56) KMT2ANPC1ALDH1A1LMNAMAPT
SCHEMBL6441494 0.63 KMT2A (0.49) POLBKMT2AMEN1NPC1LMNA
SCHEMBL16351975 0.63 TDP1 (0.43) KMT2ANPC1ALDH1A1MAPTMAPK1
SCHEMBL8486229 0.63 PTGS2 (0.64) PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1534683-A4 CYCLOOXYGENASE-2 SELECTIVE INHIBITORS, COMPOSITIONS AND METHODS OF USE NITROMED INC (US) 2005-08-24 EP disclosed
EP-1534683-A2 CYCLOOXYGENASE-2 SELECTIVE INHIBITORS, COMPOSITIONS AND METHODS OF USE Nitromed, Inc. (US) 2005-06-01 EP disclosed
WO-2004002409-A2 CYCLOOXYGENASE-2 SELECTIVE INHIBITORS, COMPOSITIONS AND METHODS OF USE NITROMED, INC. (US) 2004-01-08 WO disclosed